Literature DB >> 16085405

KIR matching in hematopoietic stem cell transplantation.

Jean-Denis Bignon1, Katia Gagne.   

Abstract

Although the key role of MHC-restricted T lymphocytes in hematopoietic stem cell transplantation (HSCT) has been known for a long time, recent data have focused on complementary or alternative effector cell populations, and in particular on NK cells. Spontaneously generated NK cell alloreactivity from stem cell grafts involves specific interactions between NK receptors, including killer immunoglobulin-like receptors (KIRs) and their MHC class I ligands. The combined effects of HLA and KIR polymorphic genes might explain discrepancies in the impact of donor-recipient matching observed in HSCT.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16085405     DOI： 10.1016/j.coi.2005.07.014

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN： 0952-7915            Impact factor:   7.486


  7 in total

Review 1.  Targeting natural killer cells and natural killer T cells in cancer.

Authors:  Eric Vivier; Sophie Ugolini; Didier Blaise; Christian Chabannon; Laurent Brossay
Journal:  Nat Rev Immunol       Date:  2012-03-22       Impact factor: 53.106

2.  The diversity of KIR gene in Chinese Northern Han population and the impact of donor KIR and patient HLA genotypes on outcome following HLA-identical sibling allogeneic hematopoietic stem cell transplantation for hematological malignancy in Chinese people.

Authors:  Li Ping Dou; De Hua Zheng; Chang Wang; Jun Hua Liu; Jing Fen Sun; Hai Jie Jin; Chun Ji Gao; Li Yu; Wan Ming Da
Journal:  Int J Hematol       Date:  2008-05       Impact factor: 2.490

3.  Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells.

Authors:  Sonja Verheyden; Soldano Ferrone; Arend Mulder; Frans H Claas; Rik Schots; Barbara De Moerloose; Yves Benoit; Christian Demanet
Journal:  Cancer Immunol Immunother       Date:  2008-10-08       Impact factor: 6.968

4.  A novel approach for quantification of KIR expression in healthy donors and pediatric recipients of hematopoietic SCTs.

Authors:  X Chen; J Knowles; R C Barfield; K A Kasow; R Madden; P Woodard; D K Srivastava; E M Horwitz; R Handgretinger; G A Hale
Journal:  Bone Marrow Transplant       Date:  2008-11-24       Impact factor: 5.483

Review 5.  Identification and utilization of donor and recipient genetic variants to predict survival after HCT: are we ready for primetime?

Authors:  Lara E Sucheston-Campbell; Alyssa Clay; Philip L McCarthy; Qianqian Zhu; Leah Preus; Marcelo Pasquini; Kenan Onel; Theresa Hahn
Journal:  Curr Hematol Malig Rep       Date:  2015-03       Impact factor: 3.952

Review 6.  Current status of haploidentical stem cell transplantation for leukemia.

Authors:  Xiao-jun Huang
Journal:  J Hematol Oncol       Date:  2008-12-31       Impact factor: 17.388

Review 7.  Natural killer cells in intracranial neoplasms: presence and therapeutic efficacy against brain tumours.

Authors:  Justyna Kmiecik; Jacques Zimmer; Martha Chekenya
Journal:  J Neurooncol       Date:  2013-10-02       Impact factor: 4.130
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.